DICER1 and ovarian cancer: Consistently, genetic variants of DICER1 have been found to modulate the risk of gastric cancer [97], endocrine tumors [98], ovarian cancer [99], testicular germ-cell tumors [98], and neurofibromatosis [100], and have been found to be associated with head and neck cancer recurrence [98] and ovarian cancer prognosis [98].